2022-12-06 17:03Pressmeddelande

Antaros Medical wins SwedenBIO Award for their innovative imaging technology

Carl Sjöberg, manager of software development, Carin Schmidt, member of the board, and CEO and co-founder Johannes Hulthe from Antaros Medical receives SwedenBIO Award from Lotta Ljungkvist, chair of SwedenBIO's board, on Dec 6, 2022.Carl Sjöberg, manager of software development, Carina Schmidt, member of the board, and CEO and co-founder Johannes Hulthe from Antaros Medical receives SwedenBIO Award from Lotta Ljungkvist, chair of SwedenBIO's board, on Dec 6, 2022.

This year’s SwedenBIO Award was given to the imaging technology company Antaros Medical, for their innovative imaging solution that aids the understanding of how medicines work in the human body.

Antaros Medical’s CEO and co-founder Johannes Hulthe received the SwedenBIO Award on December 6, in a prize ceremony held in connection with this year’s SwedenBIO Summit at Grand Hôtel in Stockholm.

Antaros Medical was founded in 2014 to utilize innovative imaging to provide critical evidence-based decision support for pharma companies in clinical development phase. Today, they have established themselves as a strategic development partner to the pharmaceutical industry, combining groundbreaking imaging with profound experience of drug development and a deep knowledge in disease mechanisms.

“Receiving this award is an incredible acknowledgment of the value that we bring. This award is also an important acknowledgment of all the work our staff carry out – this wouldn’t be possible without them,” Johannes Hulthe said.

“We know that we’re at the forefront of our technology, but none of that matters unless we can bring value to our clients. It’s fantastic to be recognized for our achievements also in this context by actors outside our client base.”

Johannes Hulthe, CEO and co-founder of Antaros Medical, receives SwedenBIO Award from Lotta Ljungqvist.

Johannes Hulthe, Antaros Medical, and  Lotta Ljungqvist, SwedenBIO.

SwedenBIO Award is given annually in collaboration with HealthCap, to a life-science company that has shown outstanding achievements and contributions to society and that exemplifies the potential of a strong Swedish life-science industry. This year’s three award finalists were Antaros Medical, Genovis, and Hansa Biopharma.

Speaking on behalf of the jury, SwedenBIO's Chair of the Board Lotta Ljungqvist said: ”We’re very pleased to give SwedenBIO Award to Antaros Medical this year. It’s an exciting innovative company that has managed to build up a broad international clientele, for which they deserve to be recognized.”

”We think it’s tremendously important to shine a light on companies that have continued to move forward in good and bad weather. We want to celebrate the success of Antaros Medical, which also represents the positive development of the life science industry at large,” said Eugen Steiner, Venture Partner at HealthCap, who handed out the award onstage at the summit.

The jury consist of SwedenBIO’s board: Lotta Ljungqvist, 4L Bioconsulting; Christine Wesström, Sobi; Anders Persson, AstraZeneca; Kertin Falck, Pfizer; Niels Abel Bonde, Novo Nordisk Sweden; Carl Kilander, HealthCap; Sana Alajmovic, Sigrid Therapeutics; and Torkel Gren, Recipharm.

Om SwedenBIO

SwedenBIO is the national association for the Swedish life science industry, representing the sector both domestically and globally. Sweden has a vibrant, innovative life science industry, strong academia, and world-leading infrastructure for research. SwedenBIO’s 330+ members are companies within pharma, biotech, diagnostics and medtech, and comprise the entire range from small start-ups to SMEs and large enterprises.


Alexandra Hoegberg
Director of Communications
Alexandra Hoegberg